日本新薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4516/E00931 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2012/10/05 | 日証協 | 167,144株 | -3.48% | 5,000株 | -97.56% | 295,555株 | +10.46% | 285,000株 | +13.09% |
2012/09/28 | 日証協 | 173,169株 | +55.81% | 205,025株 | +153.12% | 267,579株 | +26.48% | 252,001株 | +60.51% |
2012/09/21 | 日証協 | 111,144株 | +34.89% | 81,000株 | +9.76% | 211,555株 | +39.57% | 157,000株 | +42.25% |
2012/09/14 | 日証協 | 82,397株 | -31.55% | 73,797株 | +954.24% | 151,580株 | -41.65% | 110,372株 | +16.58% |
2012/09/07 | 日証協 | 120,372株 | +0.84% | 7,000株 | 0% | 259,783株 | +4% | 94,672株 | -25.34% |
2012/08/31 | 日証協 | 119,372株 | -2.45% | 7,000株 | -74.07% | 249,783株 | +5.05% | 126,800株 | +56.83% |
2012/08/24 | 日証協 | 122,372株 | -1.84% | 27,000株 | +138.94% | 237,783株 | -4.42% | 80,850株 | -54.3% |
2012/08/17 | 日証協 | 124,672株 | +25.46% | 11,300株 | -50.87% | 248,783株 | +24.53% | 176,900株 | +239.54% |
2012/08/10 | 日証協 | 99,372株 | +26.8% | 23,000株 | 0% | 199,783株 | +6.96% | 52,100株 | -66.58% |
2012/08/03 | 日証協 | 78,372株 | -21.92% | 23,000株 | +15% | 186,783株 | -17.27% | 155,900株 | +77.56% |
2012/07/27 | 日証協 | 100,372株 | -2.95% | 20,000株 | +17.3% | 225,783株 | +7.6% | 87,800株 | +22.03% |
2012/07/20 | 日証協 | 103,422株 | +9.59% | 17,050株 | -37.71% | 209,833株 | +6.09% | 71,950株 | +118.03% |
2012/07/13 | 日証協 | 94,372株 | -5.03% | 27,372株 | +148.84% | 197,783株 | +3.67% | 33,000株 | -74.62% |
2012/07/06 | 日証協 | 99,372株 | -23.72% | 11,000株 | -59.26% | 190,783株 | -19.39% | 130,000株 | +73.56% |
2012/06/29 | 日証協 | 130,272株 | +35.18% | 27,000株 | +92.86% | 236,683株 | +22.77% | 74,900株 | -33.12% |
2012/06/22 | 日証協 | 96,372株 | -14.24% | 14,000株 | -66.67% | 192,783株 | -3.02% | 112,000株 | -47.17% |
2012/06/15 | 日証協 | 112,372株 | -18.26% | 42,000株 | +740% | 198,783株 | -27.92% | 212,000株 | +99.91% |
2012/06/08 | 日証協 | 137,472株 | +15.07% | 5,000株 | -84.85% | 275,783株 | +9.53% | 106,050株 | +221.36% |
2012/06/01 | 日証協 | 119,472株 | -9.13% | 33,000株 | +135.71% | 251,783株 | -0.4% | 33,000株 | -53.59% |
※株式分割は考慮していませんのでご注意ください。
Page Top